Molecular Imaging of Stem Cells: Tracking Survival, Biodistribution, Tumorigenicity, and Immunogenicity
Open Access
- 1 January 2012
- journal article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 2 (4) , 335-345
Abstract
Being able to self-renew and differentiate into virtually all cell types, both human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) have exciting therapeutic implications for myocardial infarction, neurodegenerative disease, diabetes, and other disorders involving irreversible cell loss. However, stem cell biology remains incompletely understood despite significant advances in the field. Inefficient stem cell differentiation, difficulty in verifying successful delivery to the target organ, and problems with engraftment all hamper the transition from laboratory animal studies to human clinical trials. Although traditional histopathological techniques have been the primary approach for ex vivo analysis of stem cell behavior, these postmortem examinations are unable to further elucidate the underlying mechanisms in real time and in vivo. Fortunately, the advent of molecular imaging has led to unprecedented progress in understanding the fundamental behavior of stem cells, including their survival, biodistribution, immunogenicity, and tumorigenicity in the targeted tissues of interest. This review summarizes various molecular imaging technologies and how they have advanced the current understanding of stem cell survival, biodistribution, immunogenicity, and tumorigenicity.Keywords
This publication has 95 references indexed in Scilit:
- Immunogenicity of induced pluripotent stem cellsNature, 2011
- Radiolabeling and In Vivo Imaging of Transplanted Renal Lineages Differentiated from Human Embryonic Stem Cells in Fetal Rhesus MonkeysMolecular Imaging and Biology, 2011
- Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cellsThe International Journal of Cardiovascular Imaging, 2009
- Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenograftsProceedings of the National Academy of Sciences, 2008
- Cell tracking with optical imagingEuropean Radiology, 2008
- In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease.2007
- Adenoviral Human BCL-2 Transgene Expression Attenuates Early Donor Cell Death After Cardiomyoblast Transplantation Into Ischemic Rat HeartsCirculation, 2006
- Enhancing and Diminishing Gene Function in Human Embryonic Stem CellsStem Cells, 2004
- An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cellsProceedings of the National Academy of Sciences, 2003
- The molecular structure of green fluorescent proteinNature Biotechnology, 1996